ArticleEuropean radiology2019
Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients.
Article in European radiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.
- Comparison of the efficacy and safety of metallic ureteral stent versus polymer ureteral stent for patients with malignant ureteral obstruction: a meta-analysis of comparative trials.World journal of urology · 2026Pooled it
- Urologic oncologic emergencies: a radiologist's guide.Abdominal radiology (New York) · 2026Review
- A Customized Reinforced 8-French Ureteral Stent with End-Piece to Decrease Ureteral Obstruction and Alleviate Stent-Related Symptoms: Evaluation of 92 Patients with 319 Ureteral Stent Procedures.Research and reports in urology · 2026Article
- The challenging management of malignant ureteral obstruction: Analysis of a series of 188 cases.Current urology · 2024Article
- Unveiling the Challenges in Tandem Ureteral Stent Management for Malignant Ureteral Obstruction: Failure Rate, Risk Factors, and Durability of Their Replacement.Journal of clinical medicine · 2023Article
- Effect of ureteral stent length and implantation position on migration after implantation.Medical & biological engineering & computing · 2023Article
- Management of single double-J stent failure in malignant ureteral obstruction: tandem ureteral stenting with less frequent stent exchangeDiagnostic and interventional radiology (Ankara, Turkey) · 2023Article
- Quality of life with tandem ureteral stents compared to percutaneous nephrostomy for malignant ureteral obstruction.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022Review
- Magnetic resonance imaging of in vitro urine flow in single and tandem stented ureters subject to extrinsic ureteral obstruction.International journal of urology : official journal of the Japanese Urological Association · 2022Article
- Failure of ureteral stents subject to extrinsic ureteral obstruction and stent occlusions.International urology and nephrology · 2021Article
- Comparative study of renal drainage with different ureteral stents subject to extrinsic ureteral obstruction using an in vitro ureter-stent model.BMC urology · 2021Article
- Analysis of Ureteral Tumour Stents for Malignant Ureteral Obstruction: Towards Reshaping an Optimal Stent.Research and reports in urology · 2021Article
- 10-Year Experience with Reinforced Ureteral Stents for Malignant Ureteral Obstruction.Research and reports in urology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
Abstract
objectivesThe aim of this study was to compare single and tandem ureteral stenting in the management of malignant ureteral obstruction (MUO).
methodsOur hospital's institutional review board approved this prospective study. Between November 2014 and June 2017, single ureteral stenting was performed in 56 patients (94 renal units) and tandem ureteral stenting in 48 patients (63 renal units) for MUO. A comparative analysis of the technical success rate, patient survival, stent patency, and complications was performed.
resultsSimilar demographic data were observed in patients receiving either single or tandem ureteral stenting. The technical success rate was 93.6% (88/94) for single ureteral stenting and 95.2% (60/63) for tandem ureteral stenting. There was no difference in overall survival between patients receiving single or tandem ureteral stenting (p = 0.41), but the duration of stent patency in tandem ureteral stenting was significantly longer (p = 0.022). The mean patency time was 176.7 ± 21.3 days for single ureteral stenting, and 214.7 ± 21.0 days for tandem ureteral stenting. The complications of ureteral stenting were urinary tract infection (n = 18), lower urinary tract symptoms (n = 5), haematuria (n = 3), and stent migration (n = 1).
conclusionsTandem ureteral stenting is a safe and feasible treatment for MUO, and had better efficacy compared to single ureteral stenting. KEY POINTS: • Ureteral stenting is an established treatment for the management of malignant ureteral obstruction (MUO) • Prospective single-centre study showed that tandem ureteral stenting is a safe and feasible treatment for MUO • Tandem ureteral stenting provides longer stent patency compared to single ureteral stenting in patient with MUO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.